Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Inhalable Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Inhalable Drug Delivery Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhalable Drug Delivery Devices by region & country, by Type, and by Application.
The Inhalable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalable Drug Delivery Devices.
Market Segmentation
Report Metric
Details
Report Title
Inhalable Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Market Size Available for Years
2025-2031
Global Inhalable Drug Delivery Devices Companies Covered
Acorda Therapeutics Inc
Baxter International Inc
Bellerophon Therapeutics Inc
Zambon
Canigma A.L LTD
Edixomed Ltd
IDTx Systems, Inc.
Impel NeuroPharma Inc
Kanabo Research Ltd
Mallinckrodt Plc
Medical Developments International Ltd
Medspray BV
NeuroproteXeon Inc
Next Safety, Inc.
Nobilis Therapeutics Inc
Sandoz International GmbH
Vero biotech
Global Inhalable Drug Delivery Devices Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhalable Drug Delivery Devices Market, Segment by Type
Pressurized Metered Dose Inhalers (PMDIs)
Nebulizers
Dry Powder Inhalers (DPIs)
Others
Global Inhalable Drug Delivery Devices Market, Segment by Application
Hospital
Clinic
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inhalable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inhalable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inhalable Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Inhalable Drug Delivery Devices Product Introduction
1.2 Global Inhalable Drug Delivery Devices Market Size Forecast
1.2.1 Global Inhalable Drug Delivery Devices Sales Value (2020-2031)
1.2.2 Global Inhalable Drug Delivery Devices Sales Volume (2020-2031)
1.2.3 Global Inhalable Drug Delivery Devices Sales Price (2020-2031)
1.3 Inhalable Drug Delivery Devices Market Trends & Drivers
1.3.1 Inhalable Drug Delivery Devices Industry Trends
1.3.2 Inhalable Drug Delivery Devices Market Drivers & Opportunity
1.3.3 Inhalable Drug Delivery Devices Market Challenges
1.3.4 Inhalable Drug Delivery Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Inhalable Drug Delivery Devices Players Revenue Ranking (2024)
2.2 Global Inhalable Drug Delivery Devices Revenue by Company (2020-2025)
2.3 Global Inhalable Drug Delivery Devices Players Sales Volume Ranking (2024)
2.4 Global Inhalable Drug Delivery Devices Sales Volume by Company Players (2020-2025)
2.5 Global Inhalable Drug Delivery Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Inhalable Drug Delivery Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Inhalable Drug Delivery Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Inhalable Drug Delivery Devices
2.9 Inhalable Drug Delivery Devices Market Competitive Analysis
2.9.1 Inhalable Drug Delivery Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Inhalable Drug Delivery Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalable Drug Delivery Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pressurized Metered Dose Inhalers (PMDIs)
3.1.2 Nebulizers
3.1.3 Dry Powder Inhalers (DPIs)
3.1.4 Others
3.2 Global Inhalable Drug Delivery Devices Sales Value by Type
3.2.1 Global Inhalable Drug Delivery Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Inhalable Drug Delivery Devices Sales Value, by Type (2020-2031)
3.2.3 Global Inhalable Drug Delivery Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Inhalable Drug Delivery Devices Sales Volume by Type
3.3.1 Global Inhalable Drug Delivery Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Inhalable Drug Delivery Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Inhalable Drug Delivery Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Inhalable Drug Delivery Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Inhalable Drug Delivery Devices Sales Value by Application
4.2.1 Global Inhalable Drug Delivery Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Inhalable Drug Delivery Devices Sales Value, by Application (2020-2031)
4.2.3 Global Inhalable Drug Delivery Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Inhalable Drug Delivery Devices Sales Volume by Application
4.3.1 Global Inhalable Drug Delivery Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Inhalable Drug Delivery Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Inhalable Drug Delivery Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Inhalable Drug Delivery Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Inhalable Drug Delivery Devices Sales Value by Region
5.1.1 Global Inhalable Drug Delivery Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Inhalable Drug Delivery Devices Sales Value by Region (2020-2025)
5.1.3 Global Inhalable Drug Delivery Devices Sales Value by Region (2026-2031)
5.1.4 Global Inhalable Drug Delivery Devices Sales Value by Region (%), (2020-2031)
5.2 Global Inhalable Drug Delivery Devices Sales Volume by Region
5.2.1 Global Inhalable Drug Delivery Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Inhalable Drug Delivery Devices Sales Volume by Region (2020-2025)
5.2.3 Global Inhalable Drug Delivery Devices Sales Volume by Region (2026-2031)
5.2.4 Global Inhalable Drug Delivery Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Inhalable Drug Delivery Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Inhalable Drug Delivery Devices Sales Value, 2020-2031
5.4.2 North America Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Inhalable Drug Delivery Devices Sales Value, 2020-2031
5.5.2 Europe Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Inhalable Drug Delivery Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Inhalable Drug Delivery Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Inhalable Drug Delivery Devices Sales Value, 2020-2031
5.7.2 South America Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Inhalable Drug Delivery Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Inhalable Drug Delivery Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Inhalable Drug Delivery Devices Sales Value
6.2.1 Key Countries/Regions Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Inhalable Drug Delivery Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.3.2 United States Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.4.2 Europe Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.5.2 China Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.6.2 Japan Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.7.2 South Korea Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Inhalable Drug Delivery Devices Sales Value, 2020-2031
6.9.2 India Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Inhalable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Acorda Therapeutics Inc
7.1.1 Acorda Therapeutics Inc Company Information
7.1.2 Acorda Therapeutics Inc Introduction and Business Overview
7.1.3 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
7.1.5 Acorda Therapeutics Inc Recent Development
7.2 Baxter International Inc
7.2.1 Baxter International Inc Company Information
7.2.2 Baxter International Inc Introduction and Business Overview
7.2.3 Baxter International Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Baxter International Inc Inhalable Drug Delivery Devices Product Offerings
7.2.5 Baxter International Inc Recent Development
7.3 Bellerophon Therapeutics Inc
7.3.1 Bellerophon Therapeutics Inc Company Information
7.3.2 Bellerophon Therapeutics Inc Introduction and Business Overview
7.3.3 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
7.3.5 Bellerophon Therapeutics Inc Recent Development
7.4 Zambon
7.4.1 Zambon Company Information
7.4.2 Zambon Introduction and Business Overview
7.4.3 Zambon Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Zambon Inhalable Drug Delivery Devices Product Offerings
7.4.5 Zambon Recent Development
7.5 Canigma A.L LTD
7.5.1 Canigma A.L LTD Company Information
7.5.2 Canigma A.L LTD Introduction and Business Overview
7.5.3 Canigma A.L LTD Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Canigma A.L LTD Inhalable Drug Delivery Devices Product Offerings
7.5.5 Canigma A.L LTD Recent Development
7.6 Edixomed Ltd
7.6.1 Edixomed Ltd Company Information
7.6.2 Edixomed Ltd Introduction and Business Overview
7.6.3 Edixomed Ltd Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Edixomed Ltd Inhalable Drug Delivery Devices Product Offerings
7.6.5 Edixomed Ltd Recent Development
7.7 IDTx Systems, Inc.
7.7.1 IDTx Systems, Inc. Company Information
7.7.2 IDTx Systems, Inc. Introduction and Business Overview
7.7.3 IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Offerings
7.7.5 IDTx Systems, Inc. Recent Development
7.8 Impel NeuroPharma Inc
7.8.1 Impel NeuroPharma Inc Company Information
7.8.2 Impel NeuroPharma Inc Introduction and Business Overview
7.8.3 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Offerings
7.8.5 Impel NeuroPharma Inc Recent Development
7.9 Kanabo Research Ltd
7.9.1 Kanabo Research Ltd Company Information
7.9.2 Kanabo Research Ltd Introduction and Business Overview
7.9.3 Kanabo Research Ltd Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Kanabo Research Ltd Inhalable Drug Delivery Devices Product Offerings
7.9.5 Kanabo Research Ltd Recent Development
7.10 Mallinckrodt Plc
7.10.1 Mallinckrodt Plc Company Information
7.10.2 Mallinckrodt Plc Introduction and Business Overview
7.10.3 Mallinckrodt Plc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Mallinckrodt Plc Inhalable Drug Delivery Devices Product Offerings
7.10.5 Mallinckrodt Plc Recent Development
7.11 Medical Developments International Ltd
7.11.1 Medical Developments International Ltd Company Information
7.11.2 Medical Developments International Ltd Introduction and Business Overview
7.11.3 Medical Developments International Ltd Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Medical Developments International Ltd Inhalable Drug Delivery Devices Product Offerings
7.11.5 Medical Developments International Ltd Recent Development
7.12 Medspray BV
7.12.1 Medspray BV Company Information
7.12.2 Medspray BV Introduction and Business Overview
7.12.3 Medspray BV Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Medspray BV Inhalable Drug Delivery Devices Product Offerings
7.12.5 Medspray BV Recent Development
7.13 NeuroproteXeon Inc
7.13.1 NeuroproteXeon Inc Company Information
7.13.2 NeuroproteXeon Inc Introduction and Business Overview
7.13.3 NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Offerings
7.13.5 NeuroproteXeon Inc Recent Development
7.14 Next Safety, Inc.
7.14.1 Next Safety, Inc. Company Information
7.14.2 Next Safety, Inc. Introduction and Business Overview
7.14.3 Next Safety, Inc. Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Next Safety, Inc. Inhalable Drug Delivery Devices Product Offerings
7.14.5 Next Safety, Inc. Recent Development
7.15 Nobilis Therapeutics Inc
7.15.1 Nobilis Therapeutics Inc Company Information
7.15.2 Nobilis Therapeutics Inc Introduction and Business Overview
7.15.3 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
7.15.5 Nobilis Therapeutics Inc Recent Development
7.16 Sandoz International GmbH
7.16.1 Sandoz International GmbH Company Information
7.16.2 Sandoz International GmbH Introduction and Business Overview
7.16.3 Sandoz International GmbH Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Sandoz International GmbH Inhalable Drug Delivery Devices Product Offerings
7.16.5 Sandoz International GmbH Recent Development
7.17 Vero biotech
7.17.1 Vero biotech Company Information
7.17.2 Vero biotech Introduction and Business Overview
7.17.3 Vero biotech Inhalable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Vero biotech Inhalable Drug Delivery Devices Product Offerings
7.17.5 Vero biotech Recent Development
8 Industry Chain Analysis
8.1 Inhalable Drug Delivery Devices Industrial Chain
8.2 Inhalable Drug Delivery Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Inhalable Drug Delivery Devices Sales Model
8.5.2 Sales Channel
8.5.3 Inhalable Drug Delivery Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Inhalable Drug Delivery Devices Market Trends
Table 2. Inhalable Drug Delivery Devices Market Drivers & Opportunity
Table 3. Inhalable Drug Delivery Devices Market Challenges
Table 4. Inhalable Drug Delivery Devices Market Restraints
Table 5. Global Inhalable Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Inhalable Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 7. Global Inhalable Drug Delivery Devices Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Inhalable Drug Delivery Devices Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Inhalable Drug Delivery Devices Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Inhalable Drug Delivery Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Inhalable Drug Delivery Devices Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Inhalable Drug Delivery Devices
Table 13. Global Inhalable Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalable Drug Delivery Devices as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalable Drug Delivery Devices Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Inhalable Drug Delivery Devices Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Inhalable Drug Delivery Devices Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Inhalable Drug Delivery Devices Sales Market Share in Value by Type (2020-2025)
Table 20. Global Inhalable Drug Delivery Devices Sales Market Share in Value by Type (2026-2031)
Table 21. Global Inhalable Drug Delivery Devices Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Inhalable Drug Delivery Devices Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Inhalable Drug Delivery Devices Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Inhalable Drug Delivery Devices Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Inhalable Drug Delivery Devices Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Inhalable Drug Delivery Devices Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Inhalable Drug Delivery Devices Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Inhalable Drug Delivery Devices Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Inhalable Drug Delivery Devices Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Inhalable Drug Delivery Devices Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Inhalable Drug Delivery Devices Sales Market Share in Value by Application (2020-2025)
Table 32. Global Inhalable Drug Delivery Devices Sales Market Share in Value by Application (2026-2031)
Table 33. Global Inhalable Drug Delivery Devices Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Inhalable Drug Delivery Devices Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Inhalable Drug Delivery Devices Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Inhalable Drug Delivery Devices Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Inhalable Drug Delivery Devices Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Inhalable Drug Delivery Devices Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Inhalable Drug Delivery Devices Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Inhalable Drug Delivery Devices Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Inhalable Drug Delivery Devices Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Inhalable Drug Delivery Devices Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Inhalable Drug Delivery Devices Sales Value by Region (2020-2025) & (%)
Table 44. Global Inhalable Drug Delivery Devices Sales Value by Region (2026-2031) & (%)
Table 45. Global Inhalable Drug Delivery Devices Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Inhalable Drug Delivery Devices Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Inhalable Drug Delivery Devices Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Inhalable Drug Delivery Devices Sales Volume by Region (2020-2025) & (%)
Table 49. Global Inhalable Drug Delivery Devices Sales Volume by Region (2026-2031) & (%)
Table 50. Global Inhalable Drug Delivery Devices Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Inhalable Drug Delivery Devices Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Inhalable Drug Delivery Devices Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Inhalable Drug Delivery Devices Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Inhalable Drug Delivery Devices Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Inhalable Drug Delivery Devices Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Inhalable Drug Delivery Devices Sales Volume, (2026-2031) & (K Units)
Table 57. Acorda Therapeutics Inc Company Information
Table 58. Acorda Therapeutics Inc Introduction and Business Overview
Table 59. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
Table 61. Acorda Therapeutics Inc Recent Development
Table 62. Baxter International Inc Company Information
Table 63. Baxter International Inc Introduction and Business Overview
Table 64. Baxter International Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Baxter International Inc Inhalable Drug Delivery Devices Product Offerings
Table 66. Baxter International Inc Recent Development
Table 67. Bellerophon Therapeutics Inc Company Information
Table 68. Bellerophon Therapeutics Inc Introduction and Business Overview
Table 69. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
Table 71. Bellerophon Therapeutics Inc Recent Development
Table 72. Zambon Company Information
Table 73. Zambon Introduction and Business Overview
Table 74. Zambon Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Zambon Inhalable Drug Delivery Devices Product Offerings
Table 76. Zambon Recent Development
Table 77. Canigma A.L LTD Company Information
Table 78. Canigma A.L LTD Introduction and Business Overview
Table 79. Canigma A.L LTD Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Canigma A.L LTD Inhalable Drug Delivery Devices Product Offerings
Table 81. Canigma A.L LTD Recent Development
Table 82. Edixomed Ltd Company Information
Table 83. Edixomed Ltd Introduction and Business Overview
Table 84. Edixomed Ltd Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Edixomed Ltd Inhalable Drug Delivery Devices Product Offerings
Table 86. Edixomed Ltd Recent Development
Table 87. IDTx Systems, Inc. Company Information
Table 88. IDTx Systems, Inc. Introduction and Business Overview
Table 89. IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Offerings
Table 91. IDTx Systems, Inc. Recent Development
Table 92. Impel NeuroPharma Inc Company Information
Table 93. Impel NeuroPharma Inc Introduction and Business Overview
Table 94. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Offerings
Table 96. Impel NeuroPharma Inc Recent Development
Table 97. Kanabo Research Ltd Company Information
Table 98. Kanabo Research Ltd Introduction and Business Overview
Table 99. Kanabo Research Ltd Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Kanabo Research Ltd Inhalable Drug Delivery Devices Product Offerings
Table 101. Kanabo Research Ltd Recent Development
Table 102. Mallinckrodt Plc Company Information
Table 103. Mallinckrodt Plc Introduction and Business Overview
Table 104. Mallinckrodt Plc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Mallinckrodt Plc Inhalable Drug Delivery Devices Product Offerings
Table 106. Mallinckrodt Plc Recent Development
Table 107. Medical Developments International Ltd Company Information
Table 108. Medical Developments International Ltd Introduction and Business Overview
Table 109. Medical Developments International Ltd Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Medical Developments International Ltd Inhalable Drug Delivery Devices Product Offerings
Table 111. Medical Developments International Ltd Recent Development
Table 112. Medspray BV Company Information
Table 113. Medspray BV Introduction and Business Overview
Table 114. Medspray BV Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Medspray BV Inhalable Drug Delivery Devices Product Offerings
Table 116. Medspray BV Recent Development
Table 117. NeuroproteXeon Inc Company Information
Table 118. NeuroproteXeon Inc Introduction and Business Overview
Table 119. NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Offerings
Table 121. NeuroproteXeon Inc Recent Development
Table 122. Next Safety, Inc. Company Information
Table 123. Next Safety, Inc. Introduction and Business Overview
Table 124. Next Safety, Inc. Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Next Safety, Inc. Inhalable Drug Delivery Devices Product Offerings
Table 126. Next Safety, Inc. Recent Development
Table 127. Nobilis Therapeutics Inc Company Information
Table 128. Nobilis Therapeutics Inc Introduction and Business Overview
Table 129. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Offerings
Table 131. Nobilis Therapeutics Inc Recent Development
Table 132. Sandoz International GmbH Company Information
Table 133. Sandoz International GmbH Introduction and Business Overview
Table 134. Sandoz International GmbH Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Sandoz International GmbH Inhalable Drug Delivery Devices Product Offerings
Table 136. Sandoz International GmbH Recent Development
Table 137. Vero biotech Company Information
Table 138. Vero biotech Introduction and Business Overview
Table 139. Vero biotech Inhalable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Vero biotech Inhalable Drug Delivery Devices Product Offerings
Table 141. Vero biotech Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Inhalable Drug Delivery Devices Downstream Customers
Table 145. Inhalable Drug Delivery Devices Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalable Drug Delivery Devices Product Picture
Figure 2. Global Inhalable Drug Delivery Devices Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Inhalable Drug Delivery Devices Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Inhalable Drug Delivery Devices Sales Volume (2020-2031) & (K Units)
Figure 5. Global Inhalable Drug Delivery Devices Sales Price (2020-2031) & (US$/Unit)
Figure 6. Inhalable Drug Delivery Devices Report Years Considered
Figure 7. Global Inhalable Drug Delivery Devices Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Inhalable Drug Delivery Devices Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inhalable Drug Delivery Devices Revenue in 2024
Figure 10. Inhalable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Pressurized Metered Dose Inhalers (PMDIs) Picture
Figure 12. Nebulizers Picture
Figure 13. Dry Powder Inhalers (DPIs) Picture
Figure 14. Others Picture
Figure 15. Global Inhalable Drug Delivery Devices Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Inhalable Drug Delivery Devices Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Inhalable Drug Delivery Devices Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Inhalable Drug Delivery Devices Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Inhalable Drug Delivery Devices Price by Type (2020-2031) & (US$/Unit)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Clinic
Figure 22. Product Picture of Others
Figure 23. Global Inhalable Drug Delivery Devices Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Inhalable Drug Delivery Devices Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Inhalable Drug Delivery Devices Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Inhalable Drug Delivery Devices Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Inhalable Drug Delivery Devices Price by Application (2020-2031) & (US$/Unit)
Figure 28. North America Inhalable Drug Delivery Devices Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Inhalable Drug Delivery Devices Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Inhalable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Inhalable Drug Delivery Devices Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Inhalable Drug Delivery Devices Sales Volume (%), (2020-2031)
Figure 40. United States Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 46. China Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 48. China Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 58. India Inhalable Drug Delivery Devices Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Inhalable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
Figure 60. India Inhalable Drug Delivery Devices Sales Value by Application (%), 2024 VS 2031
Figure 61. Inhalable Drug Delivery Devices Industrial Chain
Figure 62. Inhalable Drug Delivery Devices Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives InterviewedDescription
The global market for Inhalable Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Inhalable Drug Delivery Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhalable Drug Delivery Devices by region & country, by Type, and by Application.
The Inhalable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalable Drug Delivery Devices.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inhalable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inhalable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inhalable Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
The global market for Inhalable Drug Delivery Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 134
USD 3950.00
(Single User License)
The global market for Inhalable Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 105
USD 2900.00
(Single User License)
The global Inhalable Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global Inhalable Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 109
USD 4250.00
(Single User License)
The global Inhalable Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
The global market for Inhalable Drug Delivery Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 134
The global market for Inhalable Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 105
The global Inhalable Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global Inhalable Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 109
The global Inhalable Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 129
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database